BIVI: BioVie Inc. Stock

by  •  • Comments Off on BIVI: BioVie Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 22.14
Enterprise Value ($M) 1.06
Book Value ($M) 23.92
Book Value / Share 1.30
Price / Book 0.93
NCAV ($M) 22.91
NCAV / Share 1.24
Price / NCAV 0.97

Profitability (mra)
Return on Invested Capital (ROIC) -0.88
Return on Assets (ROA) -1.13
Return on Equity (ROE) -3.24

Liquidity (mrq)
Quick Ratio 16.94
Current Ratio 16.94

Balance Sheet (mrq) ($M)
Current Assets 24.68
Assets 25.69
Liabilities 1.77
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -32.18
Net Income -32.12
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -27.95
Cash from Investing 14.53
Cash from Financing 17.80

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-11 13G/A 3i, LP 0.00 -100.00
06-25 13D/A Acuitas Group Holdings, LLC 44.53 0.00

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-02-11 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One)
2024-11-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One)
2024-09-30 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. FOR THE FISCAL YEAR ENDED JUNE 30, 2024 ☐ TRANSITION REPORT PURSUANT TO SEC
2024-05-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One)

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-03-07 71,908 172,433 41.70
2025-03-06 24,901 111,930 22.25
2025-03-05 160,635 362,476 44.32
2025-03-04 76,116 496,769 15.32

(click for more detail)

Similar Companies
BFRG – Bullfrog AI Holdings, Inc. BFRI – Biofrontera Inc.
BGM – BGM Group Ltd. BMRA – Biomerica, Inc.
BNTC – Benitec Biopharma Inc.


Financial data and stock pages provided by
Fintel.io